Performance of DNA-based biomarkers for classification of adrenocortical carcinoma: a prognostic study.
Juliane LippertUlrich DischingerSilke AppenzellerAlessandro PreteStefan KircherKassiani SkordilisYasir S ElhassanBarbara AltieriFassnacht MartinCristina L RonchiPublished in: European journal of endocrinology (2023)
Targeted DNA-based BM evaluated on routinely available FFPE samples improves prognostication of ACC beyond routinely available clinical and histopathological parameters. This approach may help to better individualise patient's management.